← All causality assessments
Causality assessment · Causality: well established

Ropinirole (dopamine agonists) and Impulse-control disorder: is the FAERS signal real?

n=92 co-reports · PRR 64.2 · ROR 64.6
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Causality: well established

Ropinirole (dopamine agonists) ↔ Impulse-control disorder

n=92 co-reports · PRR 64.2 · ROR 64.6

Like pramipexole, ropinirole can cause impulse-control disorders — pathological gambling, compulsive shopping or eating, and hypersexuality — through over-stimulation of dopamine reward pathways. The behaviours are genuine, can arise at therapeutic doses, and usually improve when the drug is withdrawn or reduced; the class carries explicit labelling. The very high PRR (64.2) again reflects how tightly this term maps to dopamine agonists.

Regulatory basis: ropinirole prescribing information (impulse-control disorders); EMA/FDA dopamine-agonist class reviews (2010s).

Bradford Hill viewpointStatusNote
Temporality (necessary)metBehaviours emerge during treatment and often resolve after dose reduction or withdrawal
StrengthmetVery high PRR, characteristic of dopamine agonists
ConsistencymetReproduced across the class and in cohort studies
SpecificitymetA distinctive dopamine-agonist effect, uncommon with other drugs
Biological gradientmetBroadly dose-related
PlausibilitymetDopamine-receptor over-stimulation of reward pathways is the mechanism
CoherencemetCoheres with the class labelling and patient warnings
ExperimentpartialDechallenge (dose reduction/withdrawal) usually reverses it; no randomized trial
AnalogymetAnalogous to impulse-control disorders with pramipexole and other dopamine agonists

This page's own qualitative read, not an automated/citation-gated assessment.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for ropinirole captured impulse-control disorder as a coded event; it is identified through clinical interview and case series rather than a trial AE table.